Affymetrix to support AAAS Newcomb Cleveland Prize
SANTA CLARA, Calif. and WASHINGTON, June 3 -- Affymetrix, Inc. (Nasdaq: AFFX) and the American Association for the Advancement of Science (AAAS) today announced Affymetrix' support of the AAAS Newcomb Cleveland Prize. The prize recognizes outstanding discoveries published in the journal, . With Affymetrix' support, the prize's monetary award will more than double to a total of $25,000 per year,...Tiny RNAs-'biological equivalent of dark matter'-wins prestigious AAAS Newcomb Cleveland Prize
The discovery of micro-sized RNA molecules (miRNAs)-a breakthrough described as "the biological equivalent of dark matter, all around us but almost escaping detection"-earned the coveted 2001-2002 AAAS Newcomb Cleveland Prize....... Three journal reports, published in the 26 October 2001 issue of Science, were named to receive the Prize, the oldest award conferred by the American Association for....NEW HAVEN, CONN., DECEMBER 8, 1999 -- VION PHARMACEUTICALS, INC. (NASDAQ NM: VION) today announced that VNP20009, the company's first generation TAPET® bacterial vector, has been administered to the first patients enrolled into Vion's Phase I intratumoral trial, which is being conducted at The Cleveland Clinic Foundation. The patients were initially monitored in the hospital and subsequent...